M2R
0.003
50%
CNJ
0.02
-73.7%
RAD
0.026
44.4%
NAE
0.002
-33.3%
MEM
0.004
33.3%
SPX
0.002
-33.3%
VKA
0.009
28.6%
RKB
0.003
-25%
RDN
0.005
25%
TAR
0.018
-25%
DRO
2.83
23%
OEL
0.004
-20%
NFM
0.017
21.4%
TDO
0.14
-17.6%
4DX
2.95
20.9%
BMO
0.033
-15.4%
VAR
0.006
20%
AX8
0.006
-14.3%
PTX
0.11
18.3%
BNL
0.006
-14.3%
BLU
0.007
16.7%
ECS
0.006
-14.3%
GLL
0.007
16.7%
ENV
0.006
-14.3%
MGL
0.245
16.7%
SER
0.006
-14.3%
VSR
0.035
16.7%
AZY
0.537
-13.4%
EOS
7.44
15.2%
ALM
0.007
-12.5%
BKB
0.8
15.1%
MML
0.028
-12.5%
SNX
0.031
14.8%
PL9
0.007
-12.5%
HPG
1.385
14.5%
SRJ
0.014
-12.5%
CLX
2.15
13.2%
GG1
0.185
-11.9%
MQR
0.009
12.5%
D3E
0.305
-11.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BOT U.S. FDA accepted new drug application

Botanix Pharmaceuticals’ (ASX:BOT) resubmission of its New Drug Application for Sofdra has been accepted by the U.S. FDA. As a result, approval of the gel is targeted for June 2024 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20240122/pdf/05zm3xd62ktg15.pdf #FDA #DrugApproval #ASX

Gold Hydrogen (ASX:GHY) energy company

Gold Hydrogen (ASX:GHY) is an energy company focused on the discovery and development of world class natural hydrogen gas in a potentially extensive natural hydrogen province in South Australia | Investor presentation: https://lnkd.in/gEwWtA6C #GHY #ASXstocks #stocks #ASXIPO

SM1 Increased forecasted based milk price for FY24

Synlait (ASX:SM1) has increased its forecasted base milk price for FY24 following perceived tightening global milk production | ASX Announcement: https://announcements.asx.com.au/asxpdf/20240119/pdf/05zkd5v17lhqls.pdf #Milk #MilkProduction #MilkPrice #SM1

PRN AU$420,000,000 in contract extensions awarded

Perenti’s (ASX:PRN) underground mining division has received ~AU$420m in contract extensions. Three of the largest contracts are for gold mines | ASX announcement: https://announcements.asx.com.au/asxpdf/20240118/pdf/05zjtq0qnfh9dc.pdf #Gold #Mining #ASX

CMH Clinical trial openfor enrollment

Chimeric Therapeutics (ASX:CHM), Australian leader in cell therapy, announces the Phase 18 ADVENT-AML clinical trial for patients with newly diagnosed Acute Myeloid Leukaemia is now open to enrolment at The University of Texas MD Anderson Cancer Center https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02762504-2A1499759

VHM (ASX:VHM): Rare earths explorer

VHM (ASX:VHM) is a rare earths explorer with a project portfolio located in an emerging rare earth province positioned in North West Victoria. The company’s projects include the Goschen Rare Earth and Mineral Sands Project and the nearby Cannie and Nowie Projects. | Investor presentation: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02742131-6A1181397 $VHM #ASX #ASXstocks #stocks #ASXIPO

The Stock Network | Australia’s freshest stock news

The Stock Network (TSN) is a business news publication creating and distributing Australia’s freshest stock news to a community of engaged investors. TSN’s unique audio and visual content illustrates the equity narratives of stocks through transcending numbers and simplifying stories to captivate stock market investors. Our core content streams include listed company news and CEO […]

5GN Acquired Security Shift

5G Networks Limited (ASX:5GN) has acquired Security Shift for $4m. The acquisition expands 5G’s cyber security and IT offering | https://announcements.asx.com.au/asxpdf/20240116/pdf/05zgng8fmb7895.pdf #5GN #SecurityShift #Cybersecurity

I88 Commences trading on the ASX

Infini Resources (ASX:I88) commenced trading on the ASX yesterday, bringing to market a new international energy metals explorer with an asset portfolio comprising Uranium & Lithium projects located in Tier 1 Canadian & West Australian mining jurisdictions https://wcsecure.weblink.com.au/pdf/I88/02762495.pdf